Hematology

June 2019 Photo Shoot

617.638.6428

Select your language:

Patients with blood disorders receive consultation and treatment for a broad range of benign conditions, such as hemoglobinopathies (sickle cell anemia and thalassemia), hemochromatosis, bleeding and thrombotic disorders (von Willebrand's disease and hemophilia), hypercoagulable states, myeloproliferative disorders, myelodysplasia and anemia, and malignancies such as leukemia, lymphoma and myeloma.

The team works closely with the blood bank and has developed innovative techniques for harvesting, storing, and re-infusing blood and its components, most notably for autologous peripheral blood stem cell infusion. Apheresis is also available for treatment of a variety of disorders including sickle cell disease, Waldenstrom's macroglobulinemia, and cryoglobulinemia.

The Infusion Suite is housed in the Center and provides patients with the utmost privacy, comfort, and convenience. The Suite includes private rooms with beds and bays with large reclining chairs for patients and comfortable seating for those who accompany them. Patient Navigators (experts trained to help patients overcome barriers to care), social workers, and dieticians are also located in the Infusion Suite and are available to help patients with any needs that arise during their visit. A specialty pharmacy is conveniently located on the floor, allowing patients to fill many of their medications without leaving the area.

Contact Us

830 Harrison Avenue, Boston, MA 02118
3rd Floor
Moakley Building 617.638.6428
Monday-Friday - 7:30 AM - 5:00 PM

Specialty Clinics

Amyloidosis Center

Boston Medical Center is an international referral center for the diagnosis and treatment of amyloidosis, a rare group of diseases caused by the abnormal accumulation of the protein amyloid in various parts of the body. This can occur as part of a bone marrow plasma cell disorder (AL), as a hereditary form (AF), an age-related form (senile systemic amyloidosis due to ATTR), or secondary to chronic inflammatory or infectious diseases (AA).

Hereditary Hemorrhagic Telangiectasia Program (HHT)

The HHT Program at Boston Medical Center includes medical providers from 10 specialties, committed to providing coordinated, excellent care including genetic counseling and testing, diagnosis, screening, and treatment to optimize the health and lives of those affected by HHT.

Pediatrics - Hematology

Boston Medical Center’s Pediatric Hematology and Oncology Program offers state-of-the-art evaluation, diagnosis, treatment of blood disorders. Genetic abnormalities of the blood, such as sickle cell disease, are a main focus of the program, but it also provides evaluation and ongoing care for children and adolescents with a variety of blood disorders and “orphan” illnesses. Physicians are also available for second opinions related to leukemia or other childhood cancers.

Sickle Cell Disease

BMC’s Center of Excellence in Sickle Cell Disease is the largest center of its kind in New England. The center’s multidisciplinary team is committed to providing patients across their lifespan with highly personalized care to manage their symptoms associated with the disease so they can live as normal a life as possible.

Conditions We Treat

Our Team

Adam Lerner, MD

Medical Oncologist

Special Interests

Chronic lymphocytic leukemia, lymphoid malignancies, sarcoma, breast cancer, and cAMP signaling

Lillian E McMahon, MD

Hematologist

Special Interests

Sickle Cell Disease, Sickle Cell Anemia, Hemoglobin C Disease, Hemoglobinopathies

Fabio Petrocca, MD

Hematologist

Special Interests

Hematologic malignancies, lymphomas, leukemias, multiple myeloma

Vaishali Sanchorawala, MD

Hematologist, Director, Amyloidosis Center, Director, Stem Cell Transplant and Cellular Therapy Program

Special Interests

Amyloidosis, stem cell transplantation, myeloma, clinical trials

J Mark Sloan, MD

Hematologist

Special Interests

AL Amyloidosis, lymphoma, leukemia, multiple myeloma, thrombosis, hemostasis, autologous stem cell transplantation.

Raphael E Szalat, MD, PHD

Multiple Myeloma program director

Special Interests

Myeloma, Monoclonal gammopathies, auto-immune cytopenia, lymphoma

Amyloidosis Team

Vaishali Sanchorawala, MD

Hematologist, Director, Amyloidosis Center, Director, Stem Cell Transplant and Cellular Therapy Program

Special Interests

Amyloidosis, stem cell transplantation, myeloma, clinical trials

J Mark Sloan, MD

Hematologist

Special Interests

AL Amyloidosis, lymphoma, leukemia, multiple myeloma, thrombosis, hemostasis, autologous stem cell transplantation.

Tracy A Joshi, DNP

Special Interests

Amyloidosis, AL Amyloidosis, Transthyretin Amyloidosis, Localized Amyloidosis

Benign Hematology Team

Adam Lerner, MD

Medical Oncologist

Special Interests

Chronic lymphocytic leukemia, lymphoid malignancies, sarcoma, breast cancer, and cAMP signaling

Fabio Petrocca, MD

Hematologist

Special Interests

Hematologic malignancies, lymphomas, leukemias, multiple myeloma

J Mark Sloan, MD

Hematologist

Special Interests

AL Amyloidosis, lymphoma, leukemia, multiple myeloma, thrombosis, hemostasis, autologous stem cell transplantation.

Raphael E Szalat, MD, PHD

Multiple Myeloma program director

Special Interests

Myeloma, Monoclonal gammopathies, auto-immune cytopenia, lymphoma

Malignant Hematology Team

Adam Lerner, MD

Medical Oncologist

Special Interests

Chronic lymphocytic leukemia, lymphoid malignancies, sarcoma, breast cancer, and cAMP signaling

Fabio Petrocca, MD

Hematologist

Special Interests

Hematologic malignancies, lymphomas, leukemias, multiple myeloma

Vaishali Sanchorawala, MD

Hematologist, Director, Amyloidosis Center, Director, Stem Cell Transplant and Cellular Therapy Program

Special Interests

Amyloidosis, stem cell transplantation, myeloma, clinical trials

J Mark Sloan, MD

Hematologist

Special Interests

AL Amyloidosis, lymphoma, leukemia, multiple myeloma, thrombosis, hemostasis, autologous stem cell transplantation.

Raphael E Szalat, MD, PHD

Multiple Myeloma program director

Special Interests

Myeloma, Monoclonal gammopathies, auto-immune cytopenia, lymphoma

Sickle Cell Disease Team

Jean-Antoine Ribeil, MD, PhD: Clinical Director, Sickle Cell Center of Excellence; Associate Professor of Medicine

Lillian E McMahon, MD

Hematologist

Special Interests

Sickle Cell Disease, Sickle Cell Anemia, Hemoglobin C Disease, Hemoglobinopathies

Stem Cell Transplant and Cellular Therapy Team

Fabio Petrocca, MD

Hematologist

Special Interests

Hematologic malignancies, lymphomas, leukemias, multiple myeloma

Vaishali Sanchorawala, MD

Hematologist, Director, Amyloidosis Center, Director, Stem Cell Transplant and Cellular Therapy Program

Special Interests

Amyloidosis, stem cell transplantation, myeloma, clinical trials

Patient Resources

Hematology Frequently Asked Questions

Our doctors may have you complete additional diagnostic tests to get a complete picture of your condition before they make treatment recommendations. When the testing is done, we will talk with you about different treatment options that are available to you.

Research Overview

Clinical trials are research studies in which people help doctors find ways to improve health and health care.

They can help answer scientific questions and find better ways to prevent, diagnose, or treat cancer. Many of today's treatments for cancer are based on the results of past clinical trials. Because of progress made through clinical trials, many people treated for cancer now live longer, and some are even cured from their disease.

Patients who are interested in joining a research study, or who would like to see if there are any ongoing trials that might be appropriate for their condition, can talk to their doctor or nurse, or call the Clinical Trials Office directly at 617.638.8265 to speak with research nurses and assistants.

Clinical Trials

The Clinical Trials Office of the Cancer Research Center coordinates BMC’s participation in several national cancer cooperative trials, directed not only at new therapies but also at prevention, education, and screening for early detection. A key component is the team’s active participation in the Southwest Oncology Group (SWOG), a national clinical trials cooperative established with National Cancer Institute (NCI) funding. BMC is the only full-member institution in New England, and is also a member of NSBBP (National Surgical Breast and Bowel program). Participation in SWOG and NSBBP clinical trials affords access to many investigational drugs and protocols sponsored by the NCI that would be unavailable otherwise. In addition, the team comprises the principal investigators for a series of clinical trials at Boston Medical Center.

Learn more about ongoing trials. Physicians who are interested in referring a patient for possible inclusion in one of these trials, should contact the Clinical Trials Office directly at 617.638.8265.

Residency and Fellowship Information

Hematology and Oncology Fellowship Program

The Hematology and Oncology fellowship program at Boston Medical Center is a combined teaching program with the Boston University Chobanian & Avedisian School of Medicine and the Boston Veterans Administration Medical Center. The fellowship is an ACGME accredited three year program, and offers three separate tracks: Hematology and Oncology; Geriatric Oncology (with fourth year Hematology option); and Hematology research training. For more information, click here.

Affiliations

Boston University Chobanian & Avedisian School of Medicine Logo

Boston University Chobanian & Avedisian School of Medicine

As the principal teaching affiliate of Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center is devoted to training future generations of healthcare professionals.  Learn more about Boston University Chobanian & Avedisian School of Medicine.

Latest from HealthCity

HealthCity is Boston Medical Center's online publication that explores the most pressing issues in healthcare. At HealthCity, we believe that healthcare must transform itself to become more equitable, sustainable, and open source.